glp-1 afib For patients with obesity and atrial fibrillation, receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested. https://www.medpagetoday.com/cardiology/arrhythmias/120327 Glucagon-like peptide-1 and atrial fibrillation

Based on previous data coming from preclinical and clinical studies and its excellent clinical safety profile, ALCAR is a promising treatment for ALS

Together, they create a synergy that addresses aging and tissue damage on multiple levels

Acknowledgements This work was partially funded by the Italian Ministry of Education (MIUR, Grant to GS) and by Sigma Tau Industrie Farmaceutiche Riunite (Grant to GR)

Mechanistic Differences: Ghrelin Agonism vs GHRH Stimulation Ipamorelin selectively binds ghrelin receptors in the hypothalamus and anterior pituitary, triggering growth hormone release without stimulating prolactin or cortisol

What is MEDVi